A new funding opportunity through the Patient-Centered Outcomes Research Institute (PCORI) will provide up to $20 million for comparative effectiveness studies of evidence-based clinical strategies to treat anxiety disorders in children, adolescents, and young adults.
The proposed study population should include at least 300 patients ages 7 to 25 with a confirmed clinical diagnosis of a primary anxiety disorder. Studies must include outcome measures to evaluate function, symptoms, fitness of treatment, and adverse effects. PCORI seeks studies with a minimum follow-up period of nine months from baseline, but prefers a one-year follow-up period.
PCORI will release a full funding announcement on Jan. 3, 2019, and hold an informational town hall session for interested applicants on Jan. 22 at noon ET. Letters of intent are due Jan. 31, by 5 pm ET, and full applications are due April 24, by 5 pm ET. Questions about the funding opportunity may be directed to email@example.com.